NEJM March 2026: Volume 394, Issue 11 – Latest Research

The persistence of Ebola virus in breast milk postpartum continues to be a concern for survivors of the disease and their infants, with new research published this week in the New England Journal of Medicine adding to the understanding of viral shedding and potential transmission risks. The study, appearing in the March 12/19, 2026 issue (Volume 394, Issue 11, pages 1138-1139), details ongoing monitoring of Ebola survivors in West Africa and highlights the prolonged detection of viral RNA in breast milk, even in the absence of symptomatic illness in the mothers.

Viral Persistence and Infant Risk

Ebola virus disease (EVD), caused by viruses of the Ebolavirus genus, is a severe and often fatal illness. Even as acute infection is well-studied, the long-term consequences for survivors, particularly regarding sexual and bodily fluid transmission, are still being investigated. A key area of concern is the potential for viral persistence in immune-privileged sites, such as the testes and, critically, breast milk. Immune-privileged sites are areas of the body where the immune system’s response is suppressed, allowing viruses to potentially hide from detection and elimination.

The new research confirms that detectable Ebola virus RNA can persist in breast milk for extended periods – in some cases, exceeding a year – after a mother has clinically recovered from EVD. It’s significant to note that the detection of viral RNA does not necessarily equate to the presence of infectious virus. RNA is the genetic material of the virus, and its presence indicates the virus was once there, but it doesn’t confirm whether the virus is still capable of replicating and causing illness. This distinction is crucial when assessing the actual risk to infants.

Study Details and Limitations

The study involved ongoing surveillance of Ebola survivors following the 2014-2016 West Africa epidemic. Researchers collected breast milk samples at regular intervals and tested them for Ebola virus RNA using reverse transcription polymerase chain reaction (RT-PCR), a highly sensitive molecular technique. The study did not attempt to culture infectious virus from the breast milk samples, which is a more definitive way to determine if the virus is still viable. This is a significant limitation, as it leaves open the question of whether the detected RNA represents infectious virus or simply remnants of past infection.

the study’s findings are observational. It does not establish a causal link between viral persistence in breast milk and illness in infants. While the researchers monitored infants for signs of Ebola, no confirmed cases of transmission via breast milk were identified within the study period. However, the lack of observed transmission does not rule out the possibility, particularly given the study’s limitations in detecting infectious virus.

What This Means for Mothers and Infants

The prolonged detection of Ebola virus RNA in breast milk underscores the complex challenges of managing the long-term health of EVD survivors. The World Health Organization (WHO) previously recommended against breastfeeding by Ebola survivors for a period of time after recovery, but guidance has evolved as more data becomes available. Current recommendations, as of late 2025, emphasize a risk-benefit assessment, taking into account the mother’s individual circumstances, the availability of safe alternatives to breastfeeding, and the local context. The WHO continues to monitor the situation and update its guidance as new evidence emerges.

For mothers who choose to breastfeed, the study reinforces the importance of close monitoring of infants for any signs of illness. Early detection and supportive care are critical in managing any potential infection. However, it’s too important to consider the significant benefits of breastfeeding, particularly in resource-limited settings where access to safe and affordable alternatives may be limited. The decision to breastfeed or not is a deeply personal one that should be made in consultation with a qualified healthcare provider.

Understanding Viral Load and Infectivity

The amount of virus present, known as the viral load, is a key factor in determining the risk of transmission. While the study detected viral RNA, it did not measure the viral load. Higher viral loads are generally associated with a greater risk of transmission. The infectivity of the virus – its ability to replicate and cause illness – can decrease over time, even if viral RNA remains detectable. Further research is needed to determine the relationship between viral RNA levels, viral load, infectivity, and the risk of transmission via breast milk.

Public Health Surveillance and Future Research

Ongoing surveillance of Ebola survivors is crucial for understanding the long-term consequences of EVD and informing public health interventions. This includes monitoring for viral persistence in various bodily fluids, as well as tracking the health of survivors and their families. The Centers for Disease Control and Prevention (CDC) plays a key role in supporting these surveillance efforts globally.

Future research should focus on several key areas. First, studies are needed to determine the prevalence of infectious virus in breast milk. This requires culturing the virus from samples, which is a complex and resource-intensive process. Second, research should investigate the factors that influence viral persistence, such as the mother’s immune status and the strain of Ebola virus. Third, studies are needed to assess the long-term health outcomes of infants exposed to Ebola virus via breast milk, even in the absence of acute illness. Finally, research should explore potential interventions to reduce viral shedding in breast milk, such as antiviral therapies.

What comes next is a continued refinement of risk assessment protocols and a commitment to providing comprehensive support to Ebola survivors and their families. The findings from this study, and ongoing research, will inform the development of evidence-based guidance that protects both mothers and infants while acknowledging the complex realities of life after Ebola.